Universe Pharmaceuticals (UPC) Current Assets (2020 - 2025)

Universe Pharmaceuticals has disclosed Current Assets across 6 years of filings, most recently posting $53.6 billion for Q3 2025.

• Current Assets for Q3 2025 came in at $53.6 billion, up 3.81% year-over-year; the trailing twelve-month figure through Sep 2025 was $53.6 billion (up 3.81% YoY), and the FY2025 annual result was $53.6 billion, up 3.81% from the prior year.
• Current Assets came in at $53.6 billion for Q3 2025 at Universe Pharmaceuticals, up from $51.6 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $53.6 billion in Q3 2025 to a low of $25.3 million in Q3 2023.
• The 5-year median for Current Assets is $51.1 million (2021), against an average of $13.2 billion.
• Across the five-year window, Current Assets slumped 100.0% in 2021 and surged 204246.6% in 2024, its largest moves.
• Universe Pharmaceuticals' Current Assets stood at $50.5 million in 2021, then slipped by 17.78% to $41.5 million in 2022, then sank by 39.12% to $25.3 million in 2023, then soared by 204246.6% to $51.6 billion in 2024, then climbed by 3.81% to $53.6 billion in 2025.
• The last three Current Assets figures came in at $53.6 billion (Q3 2025), $51.6 billion (Q3 2024), and $33.5 million (Q1 2024), per Business Quant data.